Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Dawson

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
International Journal of Environmental Research and Public Health|June 17, 2017
The Impact of Service Dogs on Engagement in Occupation among Females with Mobility Impairments: A Qualitative Descriptive StudyEllen Herlache-Pretzer, Melissa Y Winkle, Rachel Csatari, et al.
Pediatrics in Review|May 4, 2011
Case 1: abdominal pain and coffee ground emesis in a 9-year-old boy. Case 2: vomiting, headache, and seizures in a 7-year-old boy. Case 3: primary amenorrhea in a 15-year-old girlThomas C Martin, Joshua M Careskey, Heather Harle, et al.
Infectious Diseases and Therapy|April 9, 2025
Optimal Timing of Vaccination: A Narrative Review of Integrating Strategies for COVID-19, Influenza, and Respiratory Syncytial VirusPaolo Bonanni, Jung Yeon Heo, Hitoshi Honda, et al.
Open Forum Infectious Diseases|March 19, 2024
Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273Veronica Urdaneta, Daina B Esposito, Priyadarshani Dharia, et al.
Infectious Diseases and Therapy|July 8, 2025
Long-Term Impacts of Invasive Meningococcal Disease on Survivors and Their Caregivers in the United States and CanadaTodd Wolynn, John B Grimes, Sayali Nerurkar, et al.
Human Vaccines & Immunotherapeutics|March 3, 2023
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factorsLaura L Hammitt, Dean Quinn, Ewa Janczewska, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Environmental Research and Public Health|June 17, 2017
The Impact of Service Dogs on Engagement in Occupation among Females with Mobility Impairments: A Qualitative Descriptive StudyEllen Herlache-Pretzer, Melissa Y Winkle, Rachel Csatari, et al.
Pediatrics in Review|May 4, 2011
Case 1: abdominal pain and coffee ground emesis in a 9-year-old boy. Case 2: vomiting, headache, and seizures in a 7-year-old boy. Case 3: primary amenorrhea in a 15-year-old girlThomas C Martin, Joshua M Careskey, Heather Harle, et al.
Infectious Diseases and Therapy|April 9, 2025
Optimal Timing of Vaccination: A Narrative Review of Integrating Strategies for COVID-19, Influenza, and Respiratory Syncytial VirusPaolo Bonanni, Jung Yeon Heo, Hitoshi Honda, et al.
Open Forum Infectious Diseases|March 19, 2024
Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273Veronica Urdaneta, Daina B Esposito, Priyadarshani Dharia, et al.
Infectious Diseases and Therapy|July 8, 2025
Long-Term Impacts of Invasive Meningococcal Disease on Survivors and Their Caregivers in the United States and CanadaTodd Wolynn, John B Grimes, Sayali Nerurkar, et al.
Human Vaccines & Immunotherapeutics|March 3, 2023
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factorsLaura L Hammitt, Dean Quinn, Ewa Janczewska, et al.
Pageof 2